Charles Schwab Investment Management Inc United Therapeutics Corp Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 369,955 shares of UTHR stock, worth $134 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
369,955
Previous 387,793 4.6%
Holding current value
$134 Million
Previous $124 Million 7.32%
% of portfolio
0.03%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$311.04 - $363.55 $5.55 Million - $6.49 Million
-17,838 Reduced 4.6%
369,955 $133 Million
Q2 2024

Aug 12, 2024
SELL
$228.26 - $319.04 $2.43 Million - $3.4 Million
-10,644 Reduced 2.67%
387,793 $124 Million
Q1 2024

May 08, 2024
BUY
$210.76 - $249.51 $16.7 Million - $19.8 Million
79,407 Added 24.89%
398,437 $91.5 Million
Q4 2023

Feb 06, 2024
BUY
$214.88 - $256.94 $1.66 Million - $1.98 Million
7,723 Added 2.48%
319,030 $70.2 Million
Q3 2023

Nov 08, 2023
SELL
$211.82 - $248.24 $4.67 Million - $5.47 Million
-22,048 Reduced 6.61%
311,307 $70.3 Million
Q2 2023

Aug 09, 2023
BUY
$205.19 - $232.99 $3.97 Million - $4.5 Million
19,326 Added 6.15%
333,355 $73.6 Million
Q1 2023

May 11, 2023
BUY
$212.99 - $276.17 $518,204 - $671,921
2,433 Added 0.78%
314,029 $70.3 Million
Q4 2022

Feb 13, 2023
BUY
$205.95 - $280.43 $2.51 Million - $3.42 Million
12,207 Added 4.08%
311,596 $86.7 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $20.1 Million - $24.2 Million
-99,104 Reduced 24.87%
299,389 $62.7 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $1.17 Million - $1.61 Million
6,666 Added 1.7%
398,493 $93.9 Million
Q1 2022

May 13, 2022
BUY
$166.16 - $213.96 $2.19 Million - $2.82 Million
13,184 Added 3.48%
391,827 $70.3 Million
Q4 2021

Feb 11, 2022
BUY
$184.32 - $216.08 $987,586 - $1.16 Million
5,358 Added 1.44%
378,643 $81.8 Million
Q3 2021

Nov 16, 2021
BUY
$179.86 - $214.88 $347,669 - $415,363
1,933 Added 0.52%
373,285 $68.9 Million
Q2 2021

Aug 16, 2021
BUY
$170.47 - $211.93 $774,615 - $963,009
4,544 Added 1.24%
371,352 $66.6 Million
Q1 2021

May 17, 2021
BUY
$153.94 - $174.85 $2.5 Million - $2.83 Million
16,208 Added 4.62%
366,808 $61.4 Million
Q4 2020

Feb 16, 2021
BUY
$101.87 - $151.79 $796,317 - $1.19 Million
7,817 Added 2.28%
350,600 $53.2 Million
Q3 2020

Nov 13, 2020
SELL
$99.9 - $121.13 $199,899 - $242,381
-2,001 Reduced 0.58%
342,783 $34.6 Million
Q2 2020

Aug 14, 2020
BUY
$92.74 - $125.82 $871,756 - $1.18 Million
9,400 Added 2.8%
344,784 $41.7 Million
Q1 2020

May 15, 2020
BUY
$79.39 - $115.35 $710,302 - $1.03 Million
8,947 Added 2.74%
335,384 $31.8 Million
Q4 2019

Feb 07, 2020
BUY
$78.31 - $95.34 $775,817 - $944,533
9,907 Added 3.13%
326,437 $28.8 Million
Q3 2019

Nov 08, 2019
BUY
$74.85 - $85.99 $6.89 Million - $7.92 Million
92,047 Added 41.0%
316,530 $25.2 Million
Q2 2019

Aug 09, 2019
BUY
$76.06 - $120.81 $636,317 - $1.01 Million
8,366 Added 3.87%
224,483 $17.5 Million
Q1 2019

May 14, 2019
BUY
$107.15 - $126.84 $1.68 Million - $1.99 Million
15,713 Added 7.84%
216,117 $25.4 Million
Q4 2018

Feb 14, 2019
BUY
$101.4 - $128.73 $1.17 Million - $1.48 Million
11,501 Added 6.09%
200,404 $21.8 Million
Q3 2018

Nov 13, 2018
BUY
$113.81 - $129.46 $1.11 Million - $1.27 Million
9,786 Added 5.46%
188,903 $24.2 Million
Q2 2018

Aug 08, 2018
BUY
$101.14 - $118.31 $1.19 Million - $1.39 Million
11,726 Added 7.01%
179,117 $20.3 Million
Q1 2018

May 07, 2018
BUY
$107.21 - $151.94 $977,755 - $1.39 Million
9,120 Added 5.76%
167,391 $18.8 Million
Q4 2017

Jan 17, 2018
BUY
$118.58 - $151.28 $977,454 - $1.25 Million
8,243 Added 5.49%
158,271 $23.4 Million
Q3 2017

Nov 13, 2017
BUY
$114.6 - $136.81 $17.2 Million - $20.5 Million
150,028
150,028 $17.6 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email